DiaSulFer Project
DiaSulFer is exploring a new approach in the prevention and treatment of type 1 diabetes by suppressing a newly discovered type of iron-dependent cell death called ferroptosis, through the use of specific natural and synthetic hydrogen (per)sulfide donors. We aimed to examine whether such an approach will preserving the functional population of pancreatic β-cells, the key cells for insulin production, as well as the function of cells in tissues affected by diabetes.
We’re Getting the Best Results in Our Field.
DiaSulFer is exploring a new approach in the prevention and treatment of type 1 diabetes through the collaboration between these institutions:
- Leading Institution: Institute for Biological Research “Siniša Stanković”-National Institute of the Republic of Serbia, University of Belgrade (IBISS)
- Partnering Institution: Faculty of Biology, University of Belgrade
- Partnering Institution: Faculty of Medicine, University of Belgrade
- Funding Organization: Science Fund of the Republic of Serbia
